 High selenium yeast supplementation (200 mug/d) was evaluated in a double-blind, randomized, placebo-controlled trial. Intention-to-treat analyses assessed the effect on HIV-1 viral load and CD4 count after 9 months of treatment.
Selenium-treated subjects whose serum selenium increase was greater than 26.1 microg/L evidenced excellent treatment adherence, no change in HIV-1 viral load, and an increase in CD4 count. Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement of CD4 (a certain type of white cells) count. The results support the use of selenium as a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease. REFERENCE: Arch Intern Med. 2007 Jan 22;167(2):148-54. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Hurwitz BE1, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N. La section commentaire est fermée.
|
IMPORTANT NOTICE:
The informations and advices published or made available through drsuciu.com web site are not intended to replace the services of a physician, or any other therapist nor does it constitute a doctor-patient relationship. You should not use the information on this website for diagnosing or treating a medical condition or a health problem We advise you to consult your doctor regarding all matters relating to your health and in particular regarding the existence of symptoms that may require diagnosis or medical care Archives
Août 2017
Category |
Flux RSS